视网母细胞瘤:关于遗传起源,分类,传统到下一代治疗策略的最新情况
Ashutosh Pareek1, Deepanjali Kumar1, Aaushi Pareek1
1Department of Pharmacy, Banasthali Vidyapith, Banasthali, 304022, Rajasthan, India.
Heliyon
|July 8, 2024
概括
视网母细胞瘤 (RB) 治疗正在超越传统方法. 基因疗法和免疫疗法等新型疗法为患有这种常见眼癌的儿童提供了改善的结果和视力保护.
科学领域:
- 眼科医生 眼科 眼科
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
背景情况:
- 视网母细胞瘤 (RB) 是一种主要的儿童视力威胁癌症.
- 传统的治疗方法,如化疗和焦点治疗,都有局限性.
- 需要更少的侵入性,更有效的RB治疗仍然存在.
研究的目的:
- 审查RB的遗传基础,分类和常规治疗方法.
- 探索RB的新型治疗策略和药物输送系统.
- 为突出新兴的治疗方法,如基因疗法和免疫疗法RB.
主要方法:
- 对视网膜母细胞瘤治疗方式的综合文献综述.
- 对影响RB发展和治疗的遗传因素的分析.
- 对纳米医学,基因疗法和免疫疗法方法的评估.
主要成果:
- 基因的理解提升了RB治疗策略.
- 纳米尺度的输送系统增强了向瘤治疗.
- 新兴疗法显示出克服传统治疗局限性的潜力.
结论:
- 新的治疗方法对于改善RB治疗结果至关重要.
- 先进的疗法可以降低核分裂率并保持视力.
- 对基因治疗和免疫治疗的持续研究对于儿童眼癌的治疗至关重要.
相关概念视频
Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
What is Cancer?
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of patients who died from...
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of patients who died from...
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...


